Chemotherapy with 5-fluorouracil, cisplatin and streptozocin for neuroendocrine tumours

被引:0
|
作者
N C Turner
S J Strauss
D Sarker
R Gillmore
A Kirkwood
A Hackshaw
A Papadopoulou
J Bell
I Kayani
C Toumpanakis
F Grillo
A Mayer
D Hochhauser
R H Begent
M E Caplin
T Meyer
机构
[1] UCL Medical School,Department of Oncology
[2] Royal Free Campus,Department of Radiology
[3] Cancer Research UK and UCL Cancer Trials Centre,Department of Radiology
[4] Royal Free Hospital,Department of Gastroenterology
[5] University College Hospital,Department of Pathology
[6] Royal Free Hospital,Department of Oncology
[7] UCL Medical School,undefined
[8] Royal Free Campus,undefined
[9] UCL Cancer Institute,undefined
来源
British Journal of Cancer | 2010年 / 102卷
关键词
chemotherapy; NETs; Ki-67; mitotic index;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:1106 / 1112
页数:6
相关论文
共 50 条
  • [1] Chemotherapy with 5-fluorouracil, cisplatin and streptozocin for neuroendocrine tumours
    Turner, N. C.
    Strauss, S. J.
    Sarker, D.
    Gillmore, R.
    Kirkwood, A.
    Hackshaw, A.
    Papadopoulou, A.
    Bell, J.
    Kayani, I.
    Toumpanakis, C.
    Grillo, F.
    Mayer, A.
    Hochhauser, D.
    Begent, R. H.
    Caplin, M. E.
    Meyer, T.
    [J]. BRITISH JOURNAL OF CANCER, 2010, 102 (07) : 1106 - 1112
  • [2] Streptozocin, 5-fluorouracil/folinic acid and cisplatin (FCiSt) for advanced neuroendocrine tumours
    Sarker, D
    Williams, MT
    Buscombe, J
    Caplin, M
    Hochhauser, D
    Begent, R
    Meyer, T
    [J]. BRITISH JOURNAL OF CANCER, 2003, 88 : S65 - S65
  • [3] Streptozocin/5-fluorouracil chemotherapy of pancreatic neuroendocrine tumours in the era of targeted therapy
    Harald Lahner
    Annie Mathew
    Anna Lisa Klocker
    Nicole Unger
    Jens Theysohn
    Jan Rekowski
    Karl-Heinz Jöckel
    Sarah Theurer
    Kurt Werner Schmid
    Ken Herrmann
    Dagmar Führer
    [J]. Endocrine, 2022, 75 : 293 - 302
  • [4] Streptozocin/5-fluorouracil chemotherapy of pancreatic neuroendocrine tumours in the era of targeted therapy
    Lahner, Harald
    Mathew, Annie
    Klocker, Anna Lisa
    Unger, Nicole
    Theysohn, Jens
    Rekowski, Jan
    Joeckel, Karl-Heinz
    Theurer, Sarah
    Schmid, Kurt Werner
    Herrmann, Ken
    Fuehrer, Dagmar
    [J]. ENDOCRINE, 2022, 75 (01) : 293 - 302
  • [5] Streptozocin/5-fluorouracil chemotherapy is associated with durable response in patients with advanced pancreatic neuroendocrine tumours
    Dilz, Lisa-Marie
    Denecke, Timm
    Steffen, Ingo G.
    Prasad, Vikas
    von Weikersthal, Ludwig Fischer
    Pape, Ulrich-Frank
    Wiedenmann, Bertram
    Pavel, Marianne
    [J]. EUROPEAN JOURNAL OF CANCER, 2015, 51 (10) : 1253 - 1262
  • [6] Treatment of neuroendocrine tumours with infusional 5-fluorouracil, folinic acid and streptozocin
    M A Gonzalez
    S Biswas
    L Clifton
    P G Corrie
    [J]. British Journal of Cancer, 2003, 89 : 455 - 456
  • [7] Treatment of neuroendocrine tumours with infusional 5-fluorouracil, folinic acid and streptozocin
    Gonzalez, MA
    Biswas, S
    Clifton, L
    Corrie, PG
    [J]. BRITISH JOURNAL OF CANCER, 2003, 89 (03) : 455 - 456
  • [8] 5-Fluorouracil biomarkers in pancreatic neuroendocrine tumours
    de Mestier, Louis
    Cros, Jerome
    Hammel, Pascal
    [J]. PANCREATOLOGY, 2017, 17 (04) : 527 - 528
  • [9] Treatment of advanced neuroendocrine tumours using combination chemotherapy with lomustine and 5-fluorouracil
    Kaltsas, GA
    Mukherjee, JJ
    Isidori, A
    Kola, B
    Plowman, PN
    Monson, JP
    Grossman, AB
    Besser, GM
    [J]. CLINICAL ENDOCRINOLOGY, 2002, 57 (02) : 169 - 183
  • [10] Capecitabine and streptozocin ± cisplatin in advanced gastroenteropancreatic neuroendocrine tumours
    Meyer, Tim
    Qian, Wendi
    Caplin, Martyn E.
    Armstrong, Graham
    Lao-Sirieix, Si-Houy
    Hardy, Richard
    Valle, Juan W.
    Talbot, Denis C.
    Cunningham, David
    Reed, Nick
    Shaw, Ashley
    Navalkissoor, Shaunak
    Tu-Vinh Luong
    Corrie, Pippa G.
    [J]. EUROPEAN JOURNAL OF CANCER, 2014, 50 (05) : 902 - 911